Q: This stock is slowly approaching the rejected “offer” of $2.30. Do you think there is more upside? Ie Buy, sell, or hold?
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: What are your thoughts on AMWL at this much lower price?
Q: I have recently received rights issued from a common share holding in SQM. I can't locate information on the rights, e.g., right to buy at? time expiration - can you provide some insight or, alternatively, a link that provides that information. I've looked on the company website, investor news releases and looked up the rights on the TMX (ADR) but can't find anything
- Bristol-Myers Squibb Company (BMY)
- Johnson & Johnson (JNJ)
- Merck & Company Inc. (MRK)
- Pfizer Inc. (PFE)
Q: i have held this for about 5 years and it has basically done nothing despite all the promises from management for change/consolidation etc. Would you support continuing to hold or am i better switching to a better growth name. i am retired so i like a bit of income in addition to share price appreciation. i already own ABBV and MDT and do not want to add to these positions. i am better off in Merck or PFE?
Q: Hi , are these two companies buyable today after dropping off the top 50% and 20% . Any change in fundamental? thanks.
Q: Would you see any possible long term value in this company which fell by more than half following the insolvency of a large holder of the stock. Looks like the fundamentals have not changed really. Your thoughts?
Thank you.
Thank you.
Q: Hi guys - you've mentioned a few times that the market has shifted from growth to value recently. Assuming we can't time the market with any consistency over the long term, how could someone who is dollar cost averaging take advantage of theses rotations in the future from an ETF perspective? Would it make sense to buy VUG (growth) and VTV (value) and actively purchase more when one fund is considered "down"? Is there a strategic way to determine which fund you would allocate more dollars to with each monthly purchase? Thanks for the guidance.
- Fortis Inc. (FTS)
- Brookfield Renewable Partners L.P. (BEP.UN)
- Algonquin Power & Utilities Corp. (AQN)
- Northland Power Inc. (NPI)
- Capital Power Corporation (CPX)
- Innergex Renewable Energy Inc. (INE)
- Brookfield Infrastructure Partners L.P. (BIP.UN)
- TransAlta Renewables Inc. (RNW)
- Boralex Inc. Class A Shares (BLX)
Q: My question is regarding value metrics for CPX. I compared EV/Revenue for the above utilities and CPX is lowest at 4.66, followed by FTS at 5.96. FTS has the lowest P/B at 1.49; CPX is the next best at 2.00. As an income/value investor, is CPX a value diamond in the rough? I know it keeps missing estimates, but I would get a yield of about 5.5% while waiting for financial results to improve. Your comments very much appreciated.
Thanks!
Thanks!
Q: What is your opinion of this company trading at 6x pe and 20% roi ? Is it a buy now?
- Royal Bank of Canada (RY)
- Toronto-Dominion Bank (The) (TD)
- Bank of Nova Scotia (The) (BNS)
- Bank of Montreal (BMO)
- Canadian Imperial Bank Of Commerce (CM)
- National Bank of Canada (NA)
Q: For growth and potential dividend increases, would you please rank the six Canadian banks (the ‘big 5’ plus National) in order of preference to buy now?
Thanks!
Thanks!
Q: My Score Media and Gaming stock keeps dropping even when other tech stocks rebound. Any idea why? Is it time to cut my losses and move on?
Q: Is $60 M for three dispensaries in the Philadelphia area a good deal? What sort of revenue could TRUL generate from these dispensaries?
My ‘back of the envelope’ calculations:
o # of dispensaries at end of 2020: 75
o 11 added in the 4th quarter, so lets say ~64 dispensaries made full contributions for 2020 (I have not checked if there were earlier dispensary additions in 2020)
o 2020 total revenue was 521,533,000
o 521,533,000 / 64 = 8,148,953 average revenue / dispensary
So to pay $60M for 3 dispensaries seems a little rich.
I have no idea of the addressable market for these new dispensaries.
Thanks!
My ‘back of the envelope’ calculations:
o # of dispensaries at end of 2020: 75
o 11 added in the 4th quarter, so lets say ~64 dispensaries made full contributions for 2020 (I have not checked if there were earlier dispensary additions in 2020)
o 2020 total revenue was 521,533,000
o 521,533,000 / 64 = 8,148,953 average revenue / dispensary
So to pay $60M for 3 dispensaries seems a little rich.
I have no idea of the addressable market for these new dispensaries.
Thanks!
- Cencora Inc. (COR)
- Real Matters Inc. (REAL)
- Alteryx Inc. Class A (AYX)
- Palantir Technologies Inc. Class A (PLTR)
Q: Hi 5i,
Would you add to an existing position in any of these ? I know you generally frown upon averaging down but if you would in what order ?
Thanks again
Mike E
Would you add to an existing position in any of these ? I know you generally frown upon averaging down but if you would in what order ?
Thanks again
Mike E
Q: Hi 5i
I've been asleep at the wheel with Roku - looking for pullbacks and yet to start a position. What are your thoughts on it currently? Would you expect any further pullbacks, that is, do I stay patient or bite the bullet already! ?
I generally hold positions long term - sometimes too long to my detriment.
Thanks
Mike E
I've been asleep at the wheel with Roku - looking for pullbacks and yet to start a position. What are your thoughts on it currently? Would you expect any further pullbacks, that is, do I stay patient or bite the bullet already! ?
I generally hold positions long term - sometimes too long to my detriment.
Thanks
Mike E
Q: Hi 5i
Considering these two, which would you prefer for growth at this time? The aim is for growth with some income as a backup in case the intended growth doesn't materialize (fast enough :) ).
Thanks
Mike
Considering these two, which would you prefer for growth at this time? The aim is for growth with some income as a backup in case the intended growth doesn't materialize (fast enough :) ).
Thanks
Mike
Q: Can I buy XRP (Ripple) in my TFSA?
Q: Adding to my position in BEPC. Not looking for income. Where to buy in U$ cash account or C$ cash. What are the advantages or disadvantages If any.
Roy
Roy
Q: Hi 5i
In the content space would you expect Disney or Netflix to outperform the other ? I'm leaning towards DIS for the content + 'everything else' that DIS has to offer - or has it recovered sufficiently and should I reign in my expectations ?
Expecting a 2-4 year hold, longer if all goes well.
Thanks
Mike
In the content space would you expect Disney or Netflix to outperform the other ? I'm leaning towards DIS for the content + 'everything else' that DIS has to offer - or has it recovered sufficiently and should I reign in my expectations ?
Expecting a 2-4 year hold, longer if all goes well.
Thanks
Mike
Q: Hi Gang, can you please give me any information about this company? How would you rate it for2-3 years hold. Is the price of GEVO today you would buy? Is the company cheap? Thanks
Alnoor
Alnoor
Q: do you have an opinion of Tiziana Life Sciences